N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide

C22H18BrClN4O5S — CID 87839669

IUPACN-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide
SMILESO=[N+]([O-])c1ccccc1S(=O)(=O)N[C@H](COc1cnc(Cl)c(Br)c1)Cc1c[nH]c2ccccc12
InChIInChI=1S/C22H18BrClN4O5S/c23-18-10-16(12-26-22(18)24)33-13-15(9-14-11-25-19-6-2-1-5-17(14)19)27-34(31,32)21-8-4-3-7-20(21)28(29)30/h1-8,10-12,15,25,27H,9,13H2/t15-/m0/s1
InChIKeyUGICQXHLJPCSNE-HNNXBMFYSA-N
MW565.83 g/mol
LogP4.86
Rot. Bonds9

About N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide

N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide (PubChem CID 87839669) has the molecular formula C22H18BrClN4O5S and a molecular weight of 565.83 g/mol. Its IUPAC name is N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide.

Molecular Properties

Compound NameN-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide
PubChem CID87839669
Molecular FormulaC22H18BrClN4O5S
Molecular Weight565.83 g/mol
Exact Mass563.99
IUPAC NameN-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide
SMILESO=[N+]([O-])c1ccccc1S(=O)(=O)N[C@H](COc1cnc(Cl)c(Br)c1)Cc1c[nH]c2ccccc12
InChIInChI=1S/C22H18BrClN4O5S/c23-18-10-16(12-26-22(18)24)33-13-15(9-14-11-25-19-6-2-1-5-17(14)19)27-34(31,32)21-8-4-3-7-20(21)28(29)30/h1-8,10-12,15,25,27H,9,13H2/t15-/m0/s1
InChIKeyUGICQXHLJPCSNE-HNNXBMFYSA-N
XLogP4.86
TPSA127.22 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500565.83
LogP ≤ 54.86
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide?
The IUPAC name of N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide (CID 87839669) is N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide.
What is the SMILES notation for N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide?
The canonical SMILES for N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide is O=[N+]([O-])c1ccccc1S(=O)(=O)N[C@H](COc1cnc(Cl)c(Br)c1)Cc1c[nH]c2ccccc12.
What is the InChIKey of N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide?
The InChIKey is UGICQXHLJPCSNE-HNNXBMFYSA-N. The full InChI is InChI=1S/C22H18BrClN4O5S/c23-18-10-16(12-26-22(18)24)33-13-15(9-14-11-25-19-6-2-1-5-17(14)19)27-34(31,32)21-8-4-3-7-20(21)28(29)30/h1-8,10-12,15,25,27H,9,13H2/t15-/m0/s1.
What are the key properties of N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide?
N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide has a molecular weight of 565.83 g/mol, XLogP of 4.86, 9 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S)-1-[(5-bromo-6-chloro-3-pyridinyl)oxy]-3-(1H-indol-3-yl)propan-2-yl]-2-nitrobenzenesulfonamide is sourced from PubChem (CID 87839669), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).